HOME  HOME 
NEWS  NEWS 






NEWS
May 17, 2012
Print Print | 
Premier Article  Human Genome adopts rights plan to ward off Glaxo

Human Genome Sciences Inc said on Thursday it had adopted a stockholder rights plan as the biotechnology company defends itself against a $2.6 billion hostile takeover bid...
 
 
 
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this OnePass account to access Business Law Currents as part of our free trial.